Tau-PET Imaging Enables Earlier, More Accurate Alzheimer's Diagnosis

Tau-PET imaging enables earlier, more accurate Alzheimer's diagnosis

A brain imaging technology called tau-PET can improve Alzheimer's diagnostics in health care, according to a study from the University of Gothenburg. The technology enables earlier diagnosis and robustly identifies people at highest risk—even before symptoms appear.

New Study Shows Impact of Tau-Positive PET in Risk Stratification for Dementia and Alzheimer’s Disease

For people with mild cognitive impairment (MCI), new research suggests that a combination of amyloid-positive and tau-positive PET findings is linked to a nearly 70 percent risk of progressing to dementia in five years in comparison to an approximate 30 percent risk for those with amyloid β positive and tau-negative PET.

NeuroEM Closes Initial Round for Radio Wave Alzheimer's Treatment | StartUp Health Insights: Week of Jun 17, 2025 – RamaOnHealthcare

A member of StartUp Health’s Alzheimer’s Moonshot Community, NeuroEM Therapeutics uses radio frequencies to reverse cognitive decline from Alzheimer’s disease.NeuroEM Therapeutics, a Tampa, FL-based StartUp Health community member that is pioneering the use of radio frequencies to treat Alzheimer's disease, has closed initial rounds totaling $1.33M of its $5M Series A led by BlueLake.vc. The [...]

Study highlights clinical potential of tau PET scans

A new study offers a better understanding of the potential of tau PET in Alzheimer's disease patients.